Browse > Article

Production and Characterization of a Transgenic Mouse Model of Human Liver Cancer  

Li, Zhong-Shu (Department of Animal Science, College of Agriculture, Yanbian University)
Lee, Jung-Woong (Medical Genomics Research Center, Korea Research Institute of Bioscience & Biotechnology(KRIBB))
Hyun, Byung-Hwa (Disease Model Research Center, Korea Research Institute of Bioscience & Biotechnology(KRIBB))
Lee, Chul-Ho (Disease Model Research Center, Korea Research Institute of Bioscience & Biotechnology(KRIBB))
Jeong, Kyu-Shick (Disease Model Research Center, Korea Research Institute of Bioscience & Biotechnology(KRIBB))
Fang, Nan-Zhu (Department of Animal Science, College of Agriculture, Yanbian University)
Yeom, Young-Il (Medical Genomics Research Center, Korea Research Institute of Bioscience & Biotechnology(KRIBB))
Publication Information
Abstract
Transgenic mice were generated by microinjecting a plasmid DNA containing the SV40 (simian virus 40) large T antigen (Tag) gene fused with mouse albumin promoter/enhancer sequences into fertilized one-cell mouse embryos. Among eleven founder transgenic animals, four developed hepatocellular carcinoma, two showed kidney cancer and one developed skin and brain tumors. Three stable transgenic lines, #1-2, #1-6 and #1-11 were established. Members of the lines #1-6 and #1-11 reproducibly developed liver tumors by 8 to 10 weeks of age but did not exhibit any phenotypic changes in other tissues. Histological changes loading to liver tumor formation occurred with predictable kinetics and could be classified into three distinct stages; (a) newborn to 3 weeks of age, characterized by hyperplastic hepatocytes with reduced amounts of cytoplasm without any nuclear alterations, (b) between 4 to 8 weeks of age, characterized by diffuse liver cell dysplasia without observable tumor nodules, and (c) 9 weeks of age and thereafter, characterized by hepatocellular carcinomas in the background of extensive liver dysplasia. Metastasis to the lung from a liver carcinoma was observed in #1-11 founder animal. This transgenic mouse system displays similarities with human liver cancers in a number of aspects and provides a useful model for the study of molecular events involved in hepatocarcinogenesis.
Keywords
Transgenic mouse; SV40 Tag; Hepatocellular carcinoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bosch, FX, Munoz, N (1989): Epidemiology of in hepatocellular carcinoma. In: Bannasch P, Keppler D, Weber G (eds). Liver cell carcinoma. 1st ed. Kluwer Academic Publishers, The Netherlands, pp 3-14
2 Cady B (1983): Natural history of primary and secondary tumors of the liver. Semin Oneal 10:127-134
3 Dragan YP, Sargent L, Xu YD, Xy YH, Pitot HC (1993): The initiation-promotion-progression model of rat hepatocarcinogenesis. Proc Soc Exp Biol Med 202:16-24
4 Farber E, Chen Z- Y, Harris L, Lee G, Rinaudo JS, Roomi WM, Rotstein J, Semple E (1989): The biochemical-molecular pathology of the stepwise development of liver cancer: new insights and problems. In: Bannasch P, Keppler D, Weber G (eds). Liver cell carcinoma. 1st ed. Kluwer Academic Publishers, The Netherlands, pp 273-291
5 Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA (1999): Creation of human tumour cells with defined genetic elements. Nature, 400:464-468   DOI   ScienceOn
6 Preston-Martin S, Pike MC, Ross RK, Jones PK, and Henderson BE (1990): Increased cell division as a cause of human cancer. Cancer Res 50:7425-7421
7 Schafer DF, Sorrell MF (1999): Hepatocellular carcinoma. The Lancet 353:1253-1257   DOI   ScienceOn
8 Stuver SO (1998): Towards global control of liver cancer? Cancer BioI 8:299-306   DOI   ScienceOn
9 Thorgeirsson SS, Eric SR (1996): Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor a and hepatocyte growth factor in hepatocarcinogenesis. Br J Clin Pharmacol 42:43-52   DOI   ScienceOn
10 김창민 (1996): 발암유전자와 간암. 생명공학동향 3:57-63
11 Kokura K, Nakadai T, Kishimoto T, Makino Y, Muramatsu M, Tamura TA (1998): Gene expression in hepatomas. J Gastroenterol Hepatol 13:S132-141   DOI
12 Grisham JW (1996): Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment. Carcinogenesis 18:59-81   DOI   ScienceOn
13 Tzeng YJ, Zimmermann C, Guhll E, Berg B, Avantaggiati ML, Graessmann A (1998): SV40T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Oncogene 16:2103-2114   DOI   ScienceOn
14 Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL (1989): Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4:715-724
15 Gordon JW (1994): Transgenic mouse models of hepatocellular carcinoma. Hepatology 19:538-539   DOI   ScienceOn
16 Sandgren EP, Palmiter RD, Heckel JL, Brinster RL (1992): Hepatocellular carcinogenesis in albuminplasmminogen activator trangenic mice. Proc Natl Acad Sci USA 89:11523-11527
17 Gorski K, Carneiro M, Schibler U (1986): Tissuespecific in vitro transcription from the mouse albumin promoter. Cell 47:767-776   DOI   ScienceOn
18 Skamoto M Hirohashi S, Shimosato Y (1991): Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172-178   DOI   ScienceOn
19 Kanzler S, Galle PR (2000): Apoptosis and the liver. Cancer BioI 10:173-184   DOI   ScienceOn
20 Dubois N, Bennoun M, Allemand I, Molina T, Grimber G, Daudet-Monsac M, Abelanet R, Briand P (1991): Time course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. J Hepatol 13:227-239   DOI   ScienceOn
21 Hino O, Kitagawa T, Nomura K, Ohtake K, Cui L, Furuta Y, Aizawa S (1991): Hepatocarcinogenesis in transgenic mice carrying albumin-promoted SV40 T antigen gene. Jpn J Cancer Res 82:1226-1233   DOI
22 Harbst RS, Friedman N, Darnell JE Jr, Babiss LE (1989): Positive and negative regulatory elements in the mouse albumin enhancer. Proc Natl Acad Sci USA 86:1553-1557
23 Fanning E, Knippers R (1992): Structure and function of simian virus 40 large tumor antigen. Annu Rev Biochem 61:55-85   DOI   ScienceOn
24 Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT (1990): TGF $\alpha$ overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137-1146   DOI   ScienceOn
25 Sepulveda AS, Finegold MJ, Smith B, Slagle BL, DeMayo JL, Shen RF, Woo SLC, Butel JS (1989): Development of a transgenic mouse system for the lysis of stages in liver carcinogenesis using tissue-specific expression of SV40 T-Antigen controlled by regulatory elements of the human $\alpha$-1-antitrypsin gene. Cancer Research 49:6108-6117
26 Moore MA and Kitagawa T (1986): Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro. Int Rev Cytol 101: 125-173   DOI